Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tinea capitis.

Marcy S Alvarez1, Nanette B Silverberg

  • 1Department of Dermatology, Lutheran Medical Center, Brooklyn, New York, USA.

Cutis
|October 14, 2006
PubMed
Summary
This summary is machine-generated.

Tinea capitis (TC), a scalp fungal infection, is rising. Current treatments like griseofulvin fail in 20% of cases, prompting research into new therapies for this common childhood ailment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International multicenter case series of gestational dupilumab exposure in the treatment of atopic dermatitis: Maternal complications and fetal outcomes.

Journal of the American Academy of Dermatology·2025
Same author

SAIGE I: Staphylococcus aureus, Immunological, Genetic, and Environmental (SAIGE) Factors Contributing to Atopic Dermatitis and the Use of Ceramide-Containing Skincare.

Journal of drugs in dermatology : JDD·2025
Same author

SAIGE II: The Role of Staphylococcus aureus in Skin Barrier Dysfunction and the Development and Severity of Atopic Dermatitis in Young Children.

Journal of drugs in dermatology : JDD·2025
Same author

Photoprotection in Skin of Color: A Scoping Review of Barriers, Behaviors, and Pediatric Considerations.

Pediatric dermatology·2025
Same author

Systematic Review of the Epidemiology and Risk Factors for Nonsexual Transmission of Warts and Molluscum in Children.

Pediatric dermatology·2025
Same author

Autologous cell harvesting device provides repigmentation and improves quality-of-life for patients with stable vitiligo lesions in a large and diverse patient population.

Journal of the American Academy of Dermatology·2025
Same journal

Black Dots on the Scalp of a Child.

Cutis·2026
Same journal

Psoriasis and Obesity: A Clinical Review of the Bidirectional Link and Management Implications.

Cutis·2026
Same journal

Adalimumab in Lichen Planus: A Narrative Review of Treatment and Paradoxical Reactions.

Cutis·2026
Same journal

The Future of Psoriasis Care.

Cutis·2026
Same journal

Evaluating GPT-4o for Automated Classification of Skin Lesions Using the HAM10000 Dataset.

Cutis·2026
Same journal

Metastatic Primary Extramammary Paget Disease: A Case Series.

Cutis·2026
See all related articles

Area of Science:

  • Dermatology
  • Mycology
  • Infectious Diseases

Background:

  • Tinea capitis (TC) is a prevalent fungal infection affecting the scalp, hair follicles, and shafts.
  • The incidence of TC has notably increased over the last two decades.
  • Griseofulvin, a standard treatment, exhibits a cure rate of only 80%, necessitating alternative therapeutic strategies.

Purpose of the Study:

  • To review recent advancements in understanding Tinea capitis.
  • To discuss emerging therapeutic agents and strategies for TC treatment.

Main Methods:

  • Literature review of recent clinical trials and studies on Tinea capitis.
  • Synthesis of current knowledge on the epidemiology, pathogenesis, and treatment of TC.

Main Results:

Related Experiment Videos

  • The article highlights the rising prevalence of Tinea capitis.
  • It discusses the limitations of griseofulvin and the need for alternative treatments.
  • Recent clinical trials exploring new agents for TC are reviewed.

Conclusions:

  • There is a growing need for effective alternative treatments for Tinea capitis due to treatment failures with griseofulvin.
  • Further research and clinical trials are crucial for developing improved therapeutic options for this common fungal infection.